help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gveric, D.
Right arrow Articles by Cuzner, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gveric, D.
Right arrow Articles by Cuzner, M. L.
(American Journal of Pathology. 2005;166:1143-1151.)
© 2005 American Society for Investigative Pathology

tPA Receptors and the Fibrinolytic Response in Multiple Sclerosis Lesions

Djordje Gveric*, Blanca M. Herrera{dagger} and M. Louise Cuzner*

From the Department of Neuroinflammation,* Institute of Neurology, University College London, London; and Wellcome Trust Centre for Human Genetics,{dagger} University of Oxford, Oxford, United Kingdom

Axonal damage in multiple sclerosis (MS) lesions is associated with failure of fibrinolysis because of the inhibition of the plasminogen activator system. Plasma membrane receptors for tissue plasminogen activator (tPA) and plasminogen concentrate proteolytic activity on the cell surface and provide protection from inhibitors that in turn may locally enhance the fibrinolytic response. Therefore, we have investigated expression of two of these receptors in MS lesions, annexin II tetramer (AIIt) and low-density lipoprotein receptor-related protein (LRP). In acute MS lesions both AIIt and LRP were immunolocalized on macrophages and astrocytes while LRP was additionally found on neuronal cells in cortical gray matter. Western blot analysis confirmed a significant increase in AIIt in MS lesions and in a proportion of normal-appearing white matter samples, with a highly significant correlation between annexin II levels and factors associated with impeded fibrinolysis, such as plasminogen activator inhibitor-1. Immunoblotting analysis of plasmin(ogen) revealed increased levels of lysine-plasminogen in samples expressing high AIIt protein levels. Our results suggest that limited availability of tPA in MS lesions because of formation of tPA-plasminogen activator inhibitor-1 complexes reduces capability of tPA receptors to generate plasmin, which further diminishes fibrinolytic capacity in active MS lesions and possibly leads to axonal damage.




This article has been cited by other articles:


Home page
 Mult SclerHome page
L. Lovrecic, S. Ristic, N. Starcevic-Cizmarevic, B. Brajenovic-Milic, Sasa Sega Jazbec, J. Sepcic, M. Kapovic, and B. Peterlin
PAI and TPA gene polymorphisms in multiple sclerosis
Multiple Sclerosis, March 1, 2008; 14(2): 243 - 247.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.